Ignite Creation Date:
2024-05-05 @ 7:32 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00698906
Status:
COMPLETED
Last Update Posted:
2008-06-17
First Post:
2008-06-13
Brief Title:
Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix-B in Adults Aged 19-40 y
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
208129026
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Isabelle Harpigny
Old Organization:
GSK